Clinical Trial Update: Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/IIa dose-ranging clinical trial of CHRONVAC-C in chronic hepatitis C virus infection; the status of the study is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CHRONVAC-C (ChronVac-C)

Snippet

Sponsor: Tripep AB | Conditions: Chronic Hepatitis C Virus Infection | Phase 1, Phase 2 | Status: UNKNOWN